By Siddhi Mahatole Jan 29 (Reuters) - Medical device maker ResMed on Thursday beat Wall Street estimates for second-quarter profit on the back of strong demand for its devices used to manage sleep ...
AAP Newsroom on MSN
Ozempic-style drugs prove to be 'a tailwind' for Resmed
Resmed has beaten expectations with $2 billion in second-quarter revenue and says weight loss drugs are actually boosting ...
Detailed price information for Inspire Medical Systems Inc (INSP-N) from The Globe and Mail including charting and trades.
4don MSN
Defeating dementia: Don't just look after your brain - it's also your eyes, ears and even your teeth
The fact is that the health of your heart, the quality of your sleep and even the state of your gums can all affect your risk ...
The Ozlo Sleepbuds take the crown as the best overall sleep headphones thanks to their comfortability and functionality. In ...
Al-Monitor on MSN
Gaza border reopening long awaited by stranded Palestinians
By Nidal al-Mughrabi and Mahmoud Issa CAIRO/GAZA, Feb 2 (Reuters) - Cut off from family or urgently requiring hospital care, Palestinians stranded on each side of Gaza's Rafah crossing waited with ...
5d
ResMed outlines 62%–63% gross margin target for fiscal 2026 amid double-digit growth in key segments
Q2 FY2026 earnings call recap: 11% revenue growth, margin expansion, AI innovation, and updated 62–63% guidance—read key takeaways now.
You’re on the metro and notice a young girl sitting in a seat marked for disabled people. She gets up on her stop, walks out without any help, and you might think “Well, she doesn’t look sick.” But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results